Cargando…

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant

Anti-spike monoclonal antibodies have proven invaluable in preventing severe outcomes from COVID-19, including hospitalization and death. The rise of the SARS-CoV-2 delta variant begs the question of whether monoclonal antibodies maintain similar efficacy now as they had when the alpha and beta vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Horo, John C., Challener, Douglas W., Speicher, Leigh, Bosch, Wendelyn, Seville, Maria Teresa, Bierle, Dennis M., Ganesh, Ravindra, Wilker, Caroline G., Arndt, Richard F., Arndt, Lori L., Tulledge-Scheitel, Sidna M., Hanson, Sara N., Razonable, Raymund R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674496/ https://www.ncbi.nlm.nih.gov/pubmed/35120695 http://dx.doi.org/10.1016/j.mayocp.2021.12.002

Ejemplares similares

Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch
por: Razonable, Raymund R, et al.
Publicado: (2022)

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
por: Razonable, Raymund R., et al.
Publicado: (2021)

Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019
por: Razonable, Raymund R., et al.
Publicado: (2022)

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)

Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score
por: Johnson, Patrick W., et al.
Publicado: (2023)

Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
por: Yetmar, Zachary A, et al.
Publicado: (2022)

Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge
por: Bierle, Dennis M., et al.
Publicado: (2021)

518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge
por: Chesdachai, Supavit, et al.
Publicado: (2023)

Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19
por: Bierle, Dennis M., et al.
Publicado: (2021)

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
por: O’Horo, John, et al.
Publicado: (2022)

Patient Satisfaction With Providers: Do Patient Surveys Give Enough Information to Help Providers Improve Specific Behaviors
por: North, Frederick, et al.
Publicado: (2019)

Association of provider opioid prescribing practices and the Centers for Medicare and Medicaid Services hierarchical condition category score: A retrospective examination of correlation between the volume of provider-prescribed opioid medications and provider panel complexity
por: North, Frederick, et al.
Publicado: (2017)

Do primary care providers who prescribe more opioids have higher patient panel satisfaction scores?
por: North, Frederick, et al.
Publicado: (2018)

Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection
por: Comba, Isin Yagmur, et al.
Publicado: (2022)

Is a switch to a different electronic health record associated with a change in patient satisfaction?
por: North, Frederick, et al.
Publicado: (2020)

Infectious disease physician characteristics and prescription of meropenem in the hospital
por: Challener, Douglas, et al.
Publicado: (2023)

290. Hepatitis E Virus Serostatus: A Retrospective Assessment of Demographics and Comorbidities to Assess High-risk Populations
por: Stone, Eric C, et al.
Publicado: (2019)

Use of a Web-based clinical decision support system to improve abdominal aortic aneurysm screening in a primary care practice
por: Chaudhry, Rajeev, et al.
Publicado: (2012)

1340. The Effect of Continuous Renal Replacement Therapy on Body Temperature in Patients with and without Infection
por: Challener, Douglas W, et al.
Publicado: (2019)

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model
por: Razonable, Raymund R., et al.
Publicado: (2021)

Effect of visit length and a clinical decision support tool on abdominal aortic aneurysm screening rates in a primary care practice
por: Eaton, John, et al.
Publicado: (2012)

Population health challenges in primary care: What are the unfinished tasks and who should do them?
por: North, Frederick, et al.
Publicado: (2018)

Analytics and Prediction Modeling During the COVID-19 Pandemic
por: Challener, Douglas W., et al.
Publicado: (2020)

A Retrospective Analysis of Provider-to-Patient Secure Messages: How Much Are They Increasing, Who Is Doing the Work, and Is the Work Happening After Hours?
por: North, Frederick, et al.
Publicado: (2020)

COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
por: Dhand, Abhay, et al.
Publicado: (2022)

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
por: Thilagar, Bright P., et al.
Publicado: (2022)

Babesiosis: A Retrospective Review of 38 Cases in the Upper Midwest
por: Fida, Madiha, et al.
Publicado: (2019)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection
por: Yetmar, Zachary A, et al.
Publicado: (2023)

2692. Epidemiology and Risk Factors for Clostridioides difficile Infection after Pancreas Transplantation
por: Akhtar, Haris, et al.
Publicado: (2023)

2884. Incidence of Invasive Fungal Infections After Pancreas Transplantation
por: Nair, Vaisak, et al.
Publicado: (2023)

Screening for COVID-19: Patient factors predicting positive PCR test
por: Challener, Douglas W., et al.
Publicado: (2020)

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
por: Pawlowski, Colin, et al.
Publicado: (2022)

Community-Based Drive-Through and Walk-Through Testing Centers
por: Tande, Aaron J., et al.
Publicado: (2020)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants()
por: Bhakta, Shivang, et al.
Publicado: (2022)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens
por: Challener, Douglas W., et al.
Publicado: (2020)

Surgical site infections during the COVID-19 era: A retrospective, multicenter analysis
por: Smith, Bradford B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ugp9ned0qhbh5vm0qr13rq4cn